original ) (raw )Soluble suppression of tumorigenesis-2 (sST2), a new potential biomarker of response to cardiac resynchronization therapy and cardiac contractility modulation in patients with chronic heart failure
Anisa Rahmawati
Almanac of Clinical Medicine, 2021
View PDFchevron_right
Molecular markers for diagnostics of cardiac failure
Roman Esipov
Kardiologicheskii vestnik, 2018
View PDFchevron_right
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
P. Avraamides
2014
View PDFchevron_right
Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism)
Zhanna Belaya
Terapevticheskii arkhiv
View PDFchevron_right
Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
Tatiana Chernik
Russian Journal of Cardiology
View PDFchevron_right
Neopterin is a biomarker of chronic heart failure (review of modern literature)
Madina Akhmedova
Consilium Medicum, 2021
View PDFchevron_right
Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
Olga Koshelskaya
Terapevticheskii arkhiv
View PDFchevron_right
Acute and Chronic Heart Failure After Myocardial Infarction: Clinical and Functional Markers
Dianingtyas Pangastuti
"Medical & pharmaceutical journal "Pulse", 2021
View PDFchevron_right
Diagnostic Significance of Immunity Markers in Inflammatory Cardiomyopathy Patients
Kirill Zykov
Russian Journal of Cardiology, 2017
View PDFchevron_right
Influence of physical rehabilitation on oxygen and lactate status in "inotrope-dependent" patients with chronic heart failure in class III–IV
Aleksandr Marichev
CardioSomatics, 2021
View PDFchevron_right
The Clinical Significance of Evaluation Arterial Stiffness in Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
Mikhail Statsenko
Journal of Volgograd State Medical University
View PDFchevron_right
The prevalence and prognostic significance of liver disease in chronic heart failure
Olga Arisheva
2021
View PDFchevron_right
Etiology of community-acquired pneumonia in patients with chronic heart failure
Roman Kozlov
Russian Pulmonology, 2019
View PDFchevron_right
Clinical variants and outcomes of progressive chronic heart failure in individuals with hypertrphic cardiomyopathy
Olga Krasko
Russian Heart Failure Journal, 2017
View PDFchevron_right
Usefulness of Combined Right Ventricular Ejection Fraction and the Mode of End-Stage Liver Disease Score for Worsening Heart Failure in Chronic Heart Failure
Maria Lucia Mendes de Carvalho
Journal of the American College of Cardiology, 2018
View PDFchevron_right
ИЗУЧЕНИЕ РОЛИ ФАКТОРОВ РОСТА ФИБРОБЛАСТОВ (βFGF, TGFβ1), МАРКЕРОВ ВОСПАЛЕНИЯ (IL-6, TNF-α, CRP) И КОНЕЧНЫХ ПРОДУКТОВ ГЛИКИРОВАНИЯ (AGE, RAGE) У ПАЦИЕНТОВ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА И САХАРНЫМ ДИАБЕТОМ 2 ТИПА
Константин Мелкозёров
2013
View PDFchevron_right
Features of diagnostics and treatment of chronic heart failure in elderly and senile patients. Expert opinion of the Society of Experts in Heart Failure, Russian Association of Gerontologists, and Euroasian Association of Therapists
I. Strazhesko
Kardiologiia, 2018
View PDFchevron_right
Analysis of the Serum Levels of the Cytokines TNF-Α, Rankl, Opg and IL-6 in Patients with Acute Coronary Syndrome and Inflammatory Joint Disease
Velichka Popova
2018
View PDFchevron_right
Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older
Владимир Лунев
Cardiovascular Therapy and Prevention, 2020
View PDFchevron_right
Impact of the Inflammatory and Ischemic Heart Disease Markers Into the Overall Cardiovascular Mortality in Senile Citizens of a Large City (The Data from Sahr Trial)
Svetlana Shalnova
Russian journal of Cardiology, 2015
View PDFchevron_right
Acute heart failure: classification, diagnosis, general approaches to treatment
IRINA ZHIROVA
Consilium Medicum, 2021
View PDFchevron_right
Role of Transcriptional Factor NF-Κb in Development of Oxidative Stress in Heart of Rats During Systemic Inflammatory Response Induced by Bacterial Lipopolysaccharide
Anastasiia Shkodina
Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії, 2019
View PDFchevron_right
Role of systemic antiinflammatory response markers in the pathogenesis of chronic limb ischemia
Ельвіра Джалілова
ScienceRise, 2015
View PDFchevron_right
studyinG the systolic function of left Ventricle in patients with conGestiVe heart failure in combination with chronic obstructiVe pulmonary disease
Marat Yaushev
The Bulletin of Contemporary Clinical Medicine, 2015
View PDFchevron_right
A useful, innovative, and visual method to quantify fitness and heart failure
iraj alimohammadi
The FASEB Journal, 2012
View PDFchevron_right
Polymorphic variants of genes encoding Ca(2+)-transporting sarcoplasmic reticulum proteins in the progression of chronic heart failure
Leila Gal Berner
Russian Journal of Cardiology, 2019
View PDFchevron_right
The role of circulating autoantibodies in relation to proteins in structural cardiomyocytes and functional changes of the heart in patients with chronic myocarditis
Vladislav Solntsev
CardioSomatics, 2013
View PDFchevron_right
Circulating hepatocyte growth factor (HGF) in patients with comorbidity of chronic heart failure, type 2 diabetes mellitus and impaired lipid metabolism
Pavel Makarevich
Diabetes mellitus, 2013
View PDFchevron_right
Predictive role of quantification of myocardial fibrosis using delayed contrast-enhanced magnetic resonance imaging in nonischemic dilated cardiomyopathies: a systematic review and meta-analysis
Svetlana Alexandrova
Russian Journal of Cardiology, 2021
View PDFchevron_right
Аldosterone synthetase gene (CYP11B2) polymorphism and structural parameters of the left ventricle in patients with coronary heart disease, postinfarction cardiosclerosis
Maryna Dolzhenko
Zaporozhye Medical Journal, 2017
View PDFchevron_right
Safety and effectiveness of physical training in inotrop-dependent patients with compensation for chronic heart failure at the level of the III-IV functional class
Елена Демченко
CardioSomatics, 2019
View PDFchevron_right
Effects of the combined use of atorvastatin and curcetin on inflammatory biomarkers in patients with unstable angina after COVID-19 (“Long COVID”)
Aleksandr Shek
Eurasian heart journal
View PDFchevron_right
Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes
Alexander Parkhomenko
Critical Care Medicine, 2008
View PDFchevron_right
ST2 (СТИМУЛИРУЮЩИЙ ФАКТОР РОСТА) – ЦЕННЫЙ ПРОГНОСТИЧЕСКИЙ МАРКЕР ПРИ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЯХ
Alexandr Melnik
View PDFchevron_right
Патогенетические особенности формирования сердечно-сосудистого континуума при хронической обструктивной болезни легких. Pathogenic particularities of cardiovascular continuum in chronic obstructive pulmonary disease
Дмитрий Борт , Геннадий Г Тарадин
View PDFchevron_right